The DOI matches its Crossref record; 327 of the 327 references it cites were found in a registry or an index.
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SCHULMAN, S., & KEARON, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01204.x · Cited by 5,009
Self-citation(1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,055
SCHULMAN, S., ANGERÅS, U., BERGQVIST, D., ERIKSSON, B., LASSEN, M. R., & FISHER, W. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03678.x · Cited by 3,756
Self-citationGoldhaber, S. Z., Visani, L., & De Rosa, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07534-5 · Cited by 2,870
Sleight, R. B., Sleight, P., Parish, S., Appleby, P. N., Collins, R., & Baigent, C. (1988) · PubMed · Cited by 2,868
急性心筋梗塞の疑いのある17187症例におけるストレプトキナーゼ静脈内投与,アスピリン経口投与,上記2つの併用または無処置の無作偽試験 ISIS-2
Dienstl, F., Backer, G. D., Cairns, J., Pedersen, F., Kala, R., Boissel, J., Schroeder, R., Horgan, J., & Tognoni, G. (1988) · The Lancet · Cited by 2,754
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994) · The Lancet · doi:10.1016/s0140-6736(94)91161-4 · Cited by 2,744
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15692-4 · Cited by 2,557
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Self-citation(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
Wolfe, M. M., Lichtenstein, D. R., & Singh, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402407 · Cited by 1,956
(1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362401 · Cited by 1,883
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0108 · Cited by 1,863
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., Stern, B. J., Hertzberg, V. S., Frankel, M. R., Levine, S. R., Chaturvedi, S., Kasner, S. E., Benesch, C. G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043033 · Cited by 1,744
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380701 · Cited by 1,702
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,638
(1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,530
Bivalirudin for Patients with Acute Coronary Syndromes
Stone, G. W., McLaurin, B. T., Cox, D. A., Bertrand, M. E., Lincoff, A. M., Moses, J. W., White, H. D., Pocock, S. J., Ware, J. H., Feit, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062437 · Cited by 1,459
Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,243
Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa055443 · Cited by 1,228
Levine, M., Gent, M., Hirsh, J., Leclerc, J., Anderson, D., Weitz, J., Ginsberg, J., Turpie, A. G., Demers, C., Kovacs, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341101 · Cited by 1,192
Self-citationA comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr, J. P., Thompson, J. L. P., Lazar, R. M., Levin, B., Sacco, R. L., Furie, K. L., Kistler, J. P., Albers, G. W., Pettigrew, L. C., Adams, H. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011258 · Cited by 1,168
Lincoff, A. M., Bittl, J. A., Harrington, R. A., Feit, F., Kleiman, N. S., Jackman, J. D., Sarembock, I. J., Cohen, D. J., Spriggs, D., Ebrahimi, R., et al. (2003) · JAMA · doi:10.1001/jama.289.7.853 · Cited by 1,162
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,160
TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
Wilcox, R. G., Olsson, C. G., Skene, A. M., Von Der Lippe, G., Jensen, G., Hampton, J. R., & For The Asset Study Group (1988) · The Lancet · doi:10.1016/s0140-6736(88)92656-6 · Cited by 1,153
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G., Landefeld, S., & Kearon, C. (2001) · Chest · doi:10.1378/chest.119.1_suppl.108s · Cited by 1,134
Self-citationCanadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,111
Koopman, M. M. W., Prandoni, P., Piovella, F., Ockelford, P. A., Brandjes, D. P. M., van der Meer, J., Gallus, A. S., Simonneau, G., Chesterman, C. H., Prins, M. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341102 · Cited by 1,111
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Self-citationThromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
Cannegieter, S. C., Rosendaal, F. R., & Briët, E. (1994) · Circulation · doi:10.1161/01.cir.89.2.635 · Cited by 1,068
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,067
Higashi, M. K. (2002) · JAMA · doi:10.1001/jama.287.13.1690 · Cited by 1,048
Gage, B. F., Yan, Y., Milligan, P. E., Waterman, A. D., Culverhouse, R., Rich, M. W., & Radford, M. J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.017 · Cited by 1,008
Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
Klein, A. L., Grimm, R. A., Murray, R. D., Apperson-Hansen, C., Asinger, R. W., Black, I. W., Davidoff, R., Erbel, R., Halperin, J. L., Orsinelli, D. A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441901 · Cited by 951
Lipowski, Z. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92478-7 · Cited by 944
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Self-citationCrowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035241 · Cited by 919
Self-citationRisk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 919
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
Hirsh, J., Fuster, V., Ansell, J., & Halperin, J. L. (2003) · Circulation · doi:10.1161/01.cir.0000063575.17904.4e · Cited by 911
Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
Cannegieter, S. C., Rosendaal, F. R., Wintzen, A. R., van der Meer, F. J. M., Vandenbroucke, J. P., & Briet, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330103 · Cited by 908
The OASIS-6 Trial Group* (2006) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.295.13.joc60038 · Cited by 906
GRUPPOITALIANOPERLOSTUDIODELL (1990) · The Lancet · doi:10.1016/0140-6736(90)91589-3 · Cited by 906
Mewissen, M. W., Seabrook, G. R., Meissner, M. H., Cynamon, J., Labropoulos, N., & Haughton, S. H. (1999) · Radiology · doi:10.1148/radiology.211.1.r99ap4739 · Cited by 905
Hunt, D. U., Varigos, G., Dienstl, F., Lechleitner, P., DeBacker, G., Kornitzer, M., Cairns, J., Turpie, A. G. G., Fritz-Hansen, P., Skagen, K., et al. (1992) · The Lancet · Cited by 894
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa035451 · Cited by 887
Van de Werf, F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)07403-6 · Cited by 885
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2109 · Cited by 880
Cohen, A. T., Davidson, B. L., Gallus, A. S., Lassen, M. R., Prins, M. H., Tomkowski, W., Turpie, A. G. G., Egberts, J. F. M., & Lensing, A. W. A. (2006) · BMJ · doi:10.1136/bmj.38733.466748.7c · Cited by 857
Warfarin, Aspirin, or Both after Myocardial Infarction
Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., & Arnesen, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020496 · Cited by 846
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Meyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
Bern, M. M., Lokich, J. J., Wallach, S. R., Bothe, A., Benotti, P. N., Arkin, C. F., Greco, F. A., Huberman, M., & Moore, C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-423 · Cited by 788
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
(1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371001 · Cited by 784
Simonneau, G., Sors, H., Charbonnier, B., Page, Y., Laaban, J.-P., Azarian, R., Laurent, M., Hirsch, J.-L., Ferrari, E., Bosson, J.-L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371002 · Cited by 782
Landefeld, C. S., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90564-0 · Cited by 778
Beyth, R. J., Quinn, L. M., & Landefeld, C. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00198-3 · Cited by 773
Self-citationLinkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Kearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Self-citationRaschke, R. A., Reilly, B. M., Guidry, J. R., Fontana, J. R., & Srinivas, S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-9-199311010-00002 · Cited by 743
Turpie, A. G. G. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1833 · Cited by 736
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
The I.S.A.M. Study Group (1986) · New England Journal of Medicine · doi:10.1056/nejm198606053142301 · Cited by 726
Hull, R. D., Raskob, G. E., Hirsh, J., Jay, R. M., Leclerc, J. R., Geerts, W. H., Rosenbloom, D., Sackett, D. L., Anderson, C., Harrison, L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610303151801 · Cited by 722
van Walraven, C., Hart, R. G., Singer, D. E., Laupacis, A., Connolly, S., Petersen, P., Koudstaal, P. J., Chang, Y., & Hellemons, B. (2002) · JAMA · doi:10.1001/jama.288.19.2441 · Cited by 714
Simoons, M. L. (1996) · RePub (Erasmus University Rotterdam) · Cited by 706
Go, A. S., Hylek, E. M., Chang, Y., Phillips, K. A., Henault, L. E., Capra, A. M., Jensvold, N. G., Selby, J. V., & Singer, D. E. (2003) · JAMA · doi:10.1001/jama.290.20.2685 · Cited by 703
Hull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J., Sparling, T., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 700
Low-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 685
A Comparison of Reteplase with Alteplase for Acute Myocardial Infarction
(1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371603 · Cited by 676
Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
Fihn, S. D., McDonell, M., Martin, D., Henikoff, J., Vermes, D., Kent, D., White, R. H., & for the Warfarin Optimized Outpatient Follow-up Study Group* (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00005 · Cited by 671
A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
(1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351103 · Cited by 660
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 638
Gould, M. K., Dembitzer, A. D., Doyle, R. L., Hastie, T. J., & Garber, A. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00003 · Cited by 627
STROKEPREVENTIONINATRIALFIBRIL (1994) · The Lancet · doi:10.1016/s0140-6736(94)91577-6 · Cited by 621
The International Study Group (1990) · The Lancet · doi:10.1016/0140-6736(90)91590-7 · Cited by 620
Büller, H. R., Davidson, B. L., Decousus, H., Gallus, A., Gent, M., Piovella, F., Prins, M. H., Raskob, G., Segers, A. E. M., Cariou, R., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-11-200406010-00007 · Cited by 617
Wan, S., Quinlan, D. J., Agnelli, G., & Eikelboom, J. W. (2004) · Circulation · doi:10.1161/01.cir.0000137826.09715.9c · Cited by 616
LICHTMAN, M., SPIVAK, J., BOXER, L., SHATTIL, S., & HENDERSON, E. (2000) · Hematology · doi:10.1016/b978-012448510-5/50164-3 · Cited by 605
Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Genton, E., Hirsh, J., Gent, M., Sackett, D., McLoughlin, D., & Armstrong, P. (1979) · New England Journal of Medicine · doi:10.1056/nejm197910183011602 · Cited by 604
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
Schulman, S., Granqvist, S., Holmström, M., Carlsson, A., Lindmarker, P., Nicol, P., Eklund, S.-G., Nordlander, S., Lärfars, G., Leijd, B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702063360601 · Cited by 604
Self-citationThree Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450302 · Cited by 591
FINAZZI, G., MARCHIOLI, R., BRANCACCIO, V., SCHINCO, P., WISLOFF, F., MUSIAL, J., BAUDO, F., BERRETTINI, M., Testa, S., D'ANGELO, A., et al. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01340.x · Cited by 585
Prandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Büller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 583
O'Neill, D. D., Westerman, D. P., & Sacco, W. (1966) · doi:10.21236/ad0635168 · Cited by 566
Lilleyman, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90079-2 · Cited by 565
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
van der Meer, F. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.13.1557 · Cited by 538
Interactions of Warfarin with Drugs and Food
Wells, P. S., Holbrook, A. M., Crowther, N. R., & Hirsh, J. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-9-199411010-00009 · Cited by 536
Heparin : chemical and biological properties, clinical applications
Lane, D. A., & Lindahl, U. (1989) · Edward Arnold eBooks · Cited by 533
Fang, M. C., Chang, Y., Hylek, E. M., Rosand, J., Greenberg, S. M., Go, A. S., & Singer, D. E. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00005 · Cited by 532
Klein, W., Buchwald, A., Hillis, S. E., Monrad, S., Sanz, G., Turpie, A. G. G., van der Meer, J., Olaisson, E., Undeland, S., & Ludwig, K. (1997) · Circulation · doi:10.1161/01.cir.96.1.61 · Cited by 526
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G., Beyth, R. J., Kearon, C., & Schulman, S. (2004) · Chest · doi:10.1378/chest.126.3_suppl.287s · Cited by 515
Self-citationLevine, M., Hirsh, J., Arnold, A., Gent, M., Levine, M., Arnold, A., Bramwell, V., Pritchard, K. I., Stewart, D., Warr, D., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90008-6 · Cited by 510
Self-citationJb, B., & Gj, R. (1964) · PubMed · Cited by 507
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
Hull, R. D., Raskob, G. E., Rosenbloom, D., Panju, A. A., Brill-Edwards, P., Ginsberg, J. S., Hirsh, J., Martin, G. J., & Green, D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221802 · Cited by 505
Bittl, J. A., Strony, J., Brinker, J. A., Ahmed, W. H., Meckel, C. R., Chaitman, B. R., Maraganore, J., Deutsch, E., & Adelman, B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509213331204 · Cited by 492
Antman, E. M. (1996) · Circulation · doi:10.1161/01.cir.94.5.911 · Cited by 485
(1997) · Annals of Neurology · doi:10.1002/ana.410420606 · Cited by 480
Brandjes, D. P. M., Heijboer, H., Büller, H. R., de Rijk, M., Jagt, H., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272103 · Cited by 480
Bovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-4-256 · Cited by 479
Larrue, V., von Kummer, R., del Zoppo, G., & Bluhmki, E. (1997) · Stroke · doi:10.1161/01.str.28.5.957 · Cited by 474
Dolovich, L. R., Ginsberg, J. S., Douketis, J. D., Holbrook, A. M., & Cheah, G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.181 · Cited by 468
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran
Schulman, S., Wåhlander, K., Lundström, T., Clason, S. B., & Eriksson, H. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030104 · Cited by 454
Self-citationAdjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Carter, C., Hirsh, J., Genton, E., Gent, M., Turpie, G., & McLaughlin, D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198201283060401 · Cited by 436
Management of Heparin Therapy: Controlled Prospective Trial
Salzman, E. W., Deykin, D., Shapiro, R. M., & Rosenberg, R. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505152922002 · Cited by 435
Bleeding Complications in Oral Anticoagulant Therapy: An Analysis of Risk Factors
van der Meer, F. J. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130073007 · Cited by 433
van Dongen, C. J., van den Belt, A. G., Prins, M. H., & Lensing, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001100.pub2 · Cited by 433
(1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330102 · Cited by 425
van Es, R. F., Jonker, J. J., Verheugt, F. W., Deckers, J. W., & Grobbee, D. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09409-6 · Cited by 423
Berge, E., Abdelnoor, M., Nakstad, P., & Sandset, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02085-7 · Cited by 421
Prediction of the Risk of Bleeding During Anticoagulant Treatment for Venous Thromboembolism
Kuijer, P. M. M., Hutten, B. A., Prins, M. H., & Büller, H. R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.457 · Cited by 416
Pinede, L., Ninet, J., Duhaut, P., Chabaud, S., Demolombe-Rague, S., Durieu, I., Nony, P., Sanson, C., & Boissel, J.-P. (2001) · Circulation · doi:10.1161/01.cir.103.20.2453 · Cited by 408
Blocking and binding auto-antibody to intrinsic factor.
Bardhan, K. D., Hall, J. R., Spray, G. H., & Callender, S. T. (1968) · The Lancet · Cited by 401
GALLBLADDER INERTIA IN CŒLIAC DISEASE
Braganza, J., & Howat, H. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91872-1 · Cited by 400
Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism
Agnelli, G., Prandoni, P., Becattini, C., Silingardi, M., Taliani, M. R., Miccio, M., Imberti, D., Poggio, R., Ageno, W., Pogliani, E., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00008 · Cited by 400
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
Hylek, E. M. (1998) · JAMA · doi:10.1001/jama.279.9.657 · Cited by 378
Thrombolysis for acute deep vein thrombosis
Watson, L., Broderick, C., & Armon, M. P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002783.pub4 · Cited by 372
Swan, S. K., & Hursting, M. J. (2000) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.4.318.34881 · Cited by 368
Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart Valves
Saour, J. N., Sieck, J. O., Mamo, L. A. R., & Gallus, A. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220703 · Cited by 368
Magnetic-Susceptibility Measurement of Human Iron Stores
Brittenham, G. M., Farrell, D. E., Harris, J. W., Feldman, E. S., Danish, E. H., Muir, W. A., Tripp, J. H., & Bellon, E. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072703 · Cited by 367
Merli, G., Spiro, T. E., Olsson, C.-G., Abildgaard, U., Davidson, B. L., Eldor, A., Elias, D., Grigg, A., Musset, D., Rodgers, G. M., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00009 · Cited by 362
Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
Montalescot, G., White, H. D., Gallo, R., Cohen, M., Steg, P. G., Aylward, P. E. G., Bode, C., Chiariello, M., King, S. B., Harrington, R. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052711 · Cited by 359
Low-Molecular-Weight Heparin (Fragmin) During Instability in Coronary Artery Disease (FRISC)
Swahn, E., & Wallentin, L. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00486-4 · Cited by 354
Cannon, C. P., Gibson, C. M., McCabe, C. H., Adgey, A. A. J., Schweiger, M. J., Sequeira, R. F., Grollier, G., Giugliano, R. P., Frey, M., Mueller, H. S., et al. (1998) · Circulation · doi:10.1161/01.cir.98.25.2805 · Cited by 354
Levine, M. N., Hirsh, J., Gent, M., Turpie, A. G., Weitz, J., Ginsberg, J., Geerts, W., LeClerc, J., Neemeh, J., Powers, P., et al. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649783 · Cited by 353
Self-citationMonréal, M., Lafoz, E., Olivé, A., et al. (1994) · PubMed · Cited by 352
Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve Replacement
Sullivan, J. M., Harken, D. E., & Gorlin, R. (1971) · New England Journal of Medicine · doi:10.1056/nejm197106242842501 · Cited by 351
Preliminary Report of the Stroke Prevention in Atrial Fibrillation Study
Stroke Prevention in Atrial Fibrillation Study Group Investigators (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221232 · Cited by 349
Anticoagulants for acute ischaemic stroke
Sandercock, P. A., Counsell, C., & Kamal, A. K. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000024.pub3 · Cited by 346
Eriksson, B. I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1337 · Cited by 345
Wallentin, L. C., Swahn, E., Kontny, F. P., Husted, S., Lagerqvist, B., Ståhle, E., Jd, N., Dellborg, M., Geiran, O. R., Grande, P., et al. (1999) · PubMed · Cited by 338
Rothberg, M. B., Celestin, C., Fiore, L. D., Lawler, E., & Cook, J. R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00005 · Cited by 334
Petersen, J. L., Mahaffey, K. W., Hasselblad, V., Antman, E. M., Cohen, M., Goodman, S. G., Langer, A., Blazing, M. A., Le-Moigne-Amrani, A., de Lemos, J. A., et al. (2004) · JAMA · doi:10.1001/jama.292.1.89 · Cited by 333
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial
Kase, C. S., Furlan, A. J., Wechsler, L. R., Higashida, R. T., Rowley, H. A., Hart, R. G., Molinari, G. F., Frederick, L. S., Roberts, H. C., Gebel, J. M., et al. (2001) · Neurology · doi:10.1212/wnl.57.9.1603 · Cited by 332
Shorr, R. I. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.14.1665 · Cited by 324
(1999) · The Lancet · doi:10.1016/s0140-6736(98)07332-2 · Cited by 322
Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism
Research Committee of the British Thoracic Society (1992) · The Lancet · doi:10.1016/0140-6736(92)93285-u · Cited by 320
Hemorrhagic Complications of Anticoagulant Therapy
Coon, W. W. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.133.3.386 · Cited by 316
Turpie, A. G. G., Hirsh, J., Gunstensen, J., Nelson, H., & Gent, M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92070-3 · Cited by 315
Gore, J. M., Sloan, M., Price, T. R., Randall, A. M., Bovill, E., Collen, D., Forman, S., Knatterud, G. L., Sopko, G., & Terrin, M. L. (1991) · Circulation · doi:10.1161/01.cir.83.2.448 · Cited by 315
Reserpine and Gastric Secretion in Man
KROGSGAARD, A. R. (1957) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1957.tb15737.x · Cited by 313
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
Anand, S. S. (1999) · JAMA · doi:10.1001/jama.282.21.2058 · Cited by 311
Gallus, A., Tillett, J., Jackaman, J., Mills, W., & Wycherley, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91431-5 · Cited by 305
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
(1997) · The Lancet · doi:10.1016/s0140-6736(97)01180-x · Cited by 301
Gulløv, A. L., Koefoed, B. G., Petersen, P., Pedersen, T. S., Andersen, E. D., Godtfredsen, J., & Boysen, G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.14.1513 · Cited by 301
Chesebro, J. H., Fuster, V., Elveback, L. R., McGoon, D. C., Pluth, J. R., Puga, F. J., Wallace, R. B., Danielson, G. K., Orszulak, T. A., Piehler, J. M., et al. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90673-2 · Cited by 300
Monreal, M., Lafoz, E., Olive, A., del Rio, L., & Vedia, C. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642376 · Cited by 299
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy
Simoons, M. L., de Jaegere, P. P. T., van Domburg, R., Boersma, E. H., Maggioni, A. P., Mg, F., Leimberger, J., Califf, R. M., Schröder, R., Knatterud, G. L., et al. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80089-3 · Cited by 296
Andreotti, F., Testa, L., Biondi-Zoccai, G. G. L., & Crea, F. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi485 · Cited by 289
Bleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation
(1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040081009 · Cited by 283
Maggioni, A. P., Franzosi, M. G., Santoro, E., White, H., Van de Werf, F., & Tognoni, G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207023270101 · Cited by 281
Wilcox, R. G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92224-5 · Cited by 281
Gitter, M. J., Jaeger, T. M., Petterson, T. M., Gersh, B. J., & Silverstein, M. D. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.8.725 · Cited by 276
Development of a Contemporary Bleeding Risk Model for Elderly Warfarin Recipients
Shireman, T. I., Mahnken, J. D., Howard, P. A., Kresowik, T. F., Hou, Q., & Ellerbeck, E. F. (2006) · Chest · doi:10.1378/chest.130.5.1390 · Cited by 270
Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis
Hull, R. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.8.1589 · Cited by 260
Kearon, C., Ginsberg, J. S., Julian, J. A., Douketis, J., Solymoss, S., Ockelford, P., Jackson, S., Turpie, A. G., MacKinnon, B., Hirsh, J., et al. (2006) · JAMA · doi:10.1001/jama.296.8.935 · Cited by 259
Self-citationBerkowitz, S. D., Granger, C. B., Pieper, K. S., Lee, K. L., Gore, J. M., Simoons, M., Armstrong, P. W., Topol, E. J., & Califf, R. M. (1997) · Circulation · doi:10.1161/01.cir.95.11.2508 · Cited by 256
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial
Bath, P. M., Lindenstrom, E., Boysen, G., De Deyn, P., Friis, P., Leys, D., Marttila, R., Olsson, J.-E., O'Neill, D., Orgogozo, J.-M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05837-8 · Cited by 255
HÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPY
Mant, M., Thong, K. L., Birtwhistle, R., O'Brien, B., Hammond, G., & Grace, M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92388-1 · Cited by 242
Gurwitz, J. H., Gore, J. M., Goldberg, R. J., Barron, H. V., Breen, T., Rundle, A. C., Sloan, M. A., French, W., & Rogers, W. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00002 · Cited by 233
Sethi, G. K., Copeland, J. G., Goldman, S., Moritz, T., Zadina, K., & Henderson, W. G. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90168-o · Cited by 233
White, H. D., Aylward, P. E., Frey, M. J., Adgey, A. A. J., Nair, R., Hillis, W. S., Shalev, Y., Brown, M. A., French, J. K., Collins, R., et al. (1997) · Circulation · doi:10.1161/01.cir.96.7.2155 · Cited by 232
Simonneau, G. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130045005 · Cited by 232
Pérez-Gómez, F., Alegría, E., Berjón, J., Iriarte, J. A., Zumalde, J., Salvador, A., & Mataix, L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.084 · Cited by 232
Acar, J., Iung, B., Boissel, J. P., Samama, M. M., Michel, P. L., Teppe, J. P., Pony, J. C., Le Breton, H., Thomas, D., Isnard, R., et al. (1996) · Circulation · doi:10.1161/01.cir.94.9.2107 · Cited by 229
Shireman, T. I., Howard, P. A., Kresowik, T. F., & Ellerbeck, E. F. (2004) · Stroke · doi:10.1161/01.str.0000141933.75462.c2 · Cited by 229
Gulløv, A. L., Koefoed, B. G., & Petersen, P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.12.1322 · Cited by 229
Hellemons, B. S. P., Langenberg, M., Lodder, J., Vermeer, F., Schouten, H. J. A., Lemmens, T., van Ree, J. W., & Knottnerus, J. A. (1999) · BMJ · doi:10.1136/bmj.319.7215.958 · Cited by 226
Healey, J. S., Hart, R. G., Pogue, J., Pfeffer, M. A., Hohnloser, S. H., De Caterina, R., Flaker, G., Yusuf, S., & Connolly, S. J. (2008) · Stroke · doi:10.1161/strokeaha.107.500199 · Cited by 225
Hemorrhagic Transformation in Acute Ischemic Stroke: The MAST-E Study
Jaillard, A., Cornu, C., Durieux, A., Moulin, T., Boutitie, F., Lees, K. R., & Hommel, M. (1999) · Stroke · doi:10.1161/01.str.30.7.1326 · Cited by 225
Fiore, L. D., Ezekowitz, M. D., Brophy, M. T., Lu, D., Sacco, J., & Peduzzi, P. (2002) · Circulation · doi:10.1161/hc0502.103329 · Cited by 224
YASAKA, M., MINEMATSU, K., & YAMAGUCHI, T. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.1183 · Cited by 221
Efficacy and Toxicity of Heparin in Relation to Age and Sex
Jick, H., Slone, D., Borda, I. T., & Shapiro, S. (1968) · New England Journal of Medicine · doi:10.1056/nejm196808082790603 · Cited by 220
Pini, M., Aiello, S., Manotti, C., Pattacini, C., Quintavalla, R., Poli, T., Tagliaferri, A., & Dettoi, A. G. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648837 · Cited by 218
Landefeld, C. S., Rosenblatt, M. W., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90565-2 · Cited by 211
Lindmarker, P., Holmström, M., Granqvist, S., Johnsson, H., & Lockner, D. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648836 · Cited by 210
Randomized Prospective Trial of Continuous vs Intermittent Heparin Therapy
Glazier, R. L. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270130027021 · Cited by 205
Lewis, B. E., Matthai, W. H., Cohen, M., Moses, J. W., Hursting, M. J., & Leya, F. (2002) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.10276 · Cited by 205
Morocutti, C., Amabile, G., Fattapposta, F., Nicolosi, A., Matteoli, S., Trappolini, M., Cataldo, G., Milanesi, G., Lavezzari, M., Pamparana, F., et al. (1997) · Stroke · doi:10.1161/01.str.28.5.1015 · Cited by 200
Neumann-Haefelin, T., Hoelig, S., Berkefeld, J., Fiehler, J., Gass, A., Humpich, M., Kastrup, A., Kucinski, T., Lecei, O., Liebeskind, D. S., et al. (2006) · Stroke · doi:10.1161/01.str.0000239321.53203.ea · Cited by 200
Major bleeding after hospitalization for deep-venous thrombosis
White, R. H., Beyth, R. J., Zhou, H., & Romano, P. S. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00267-3 · Cited by 198
Self-citationCollins, R., MacMahon, S., Flather, M., Baigent, C., Remvig, L., Mortensen, S., Appleby, P., Godwin, J., Yusuf, S., & Peto, R. (1996) · BMJ · doi:10.1136/bmj.313.7058.652 · Cited by 196
Breddin, H. K., Hach-Wunderle, V., Nakov, R., & Kakkar, V. V. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440902 · Cited by 195
Cited by
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Self-citation2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.019 · Cited by 2,625
Metadata
- Authors
- Schulman, S., Beyth, R. J., Kearon, C., & Levine, M. N.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 133
- Issue
- 6
- Pages
- 257S-298S
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2110167268
- Cited by
- 740
- References
- 327
- FWCI
- 41.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.